NEWPORT BEACH, Calif.--(BUSINESS WIRE)--
Evolus, Inc.
(NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will participate in fireside chats and investor meetings at upcoming investor conferences in Miami, FL:
- The Leerink Partners Global Biopharma Conference, the fireside chat will take place on Tuesday, March 11, 2025, at 9:20 AM ET.
- The Barclays 27th Annual Global Healthcare Conference, the fireside chat will take place on Wednesday, March 12, 2025, at 3:30 PM ET.
The fireside chats can be accessed on the Investor Relations page of the Evolus website
here. A replay of the webcast will be available for 90 days after the date of each presentation.
About Evolus, Inc.
Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau®
(prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse™
, a collection of unique injectable hyaluronic acid (HA) gels. Visit us at
www.evolus.com, and follow us on
LinkedIn,
X,
Instagram
or
Facebook.
Jeuveau®
and Nuceiva®
, are registered trademarks and Evolysse™
is a trademark of Evolus, Inc.
Source: Evolus